SEC reporting owner

Norden Gregory SEC insider disclosures

Explore Norden Gregory's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001405104
Issuers
8
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

WYETH0000005187WYEYesNo
HUMAN GENOME SCIENCES INC0000901219HGSINoYes
Zoetis Inc.0001555280ZTSNoYes
NanoString Technologies Inc0001401708NSTGNoYes
K-V Pharmaceutical Co0000057055KVANoYes
Entasis Therapeutics Holdings Inc.0001724344ETTXNoYes
Royalty Pharma plc0001802768RPRXNoYes
Praxis Precision Medicines, Inc.0001689548PRAXNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-06-132026-06-10PRAXA1,371Not reported
2026-06-132026-06-10PRAXA648Not reported
2026-06-092026-06-05RPRXA4,545Not reported
2026-05-162026-05-14RPRXS3,045Not reported
2026-02-202026-02-18ZTSA1,936Not reported
2025-08-122025-08-11RPRXS33,500Not reported
2025-06-282025-06-26PRAXA10,520Not reported
2025-05-152025-05-13RPRXA7,614Not reported
2025-02-212025-02-19ZTSA1,596Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.